InvestorsHub Logo

EZ2

Followers 213
Posts 219062
Boards Moderated 2
Alias Born 03/31/2001

EZ2

Re: BullNBear52 post# 120310

Thursday, 03/07/2019 7:21:27 AM

Thursday, March 07, 2019 7:21:27 AM

Post# of 120381
Health Venture Unveils Name, Site -- WSJ

DOW JONES & COMPANY, INC. 2:47 AM ET 3/7/2019
Symbol Last Price Change
AMZN 1668.95down 0 (0%)
BRK/A 301375down 0 (0%)
JPM 103.72down 0 (0%)
UNH 239.07down 0 (0%)
QUOTES AS OF 04:00:00 PM ET 03/06/2019

This article is being republished as part of our daily reproduction of WSJ.com articles that also appeared in the U.S. print edition of The Wall Street Journal (March 7, 2019).

The high-profile health-care venture launched last year by Amazon.com Inc.(AMZN), Berkshire Hathaway Inc.(BRK/A) and JPMorgan Chase & Co.(JPM) finally has a name: Haven.

The new company, which has formally released almost no information about its plans, is also unveiling a website, which includes a letter from Chief Executive Atul Gawande, a well-known writer and surgeon. But the site appears to add little new detail on the venture's plans. Some information already had emerged in an ongoing court case filed by UnitedHealth Group Inc.(UNH) against one of its own former employees, who is now working for Haven.

Dr. Gawande's letter says that Haven "will create new solutions and work to change systems, technologies, contracts, policy and whatever else is in the way of better health care."

Haven, which was incorporated in Delaware as a limited liability company formally named Tcorp62018, will initially focus on the employees of the three founding companies, according to a screenshot from the new website, echoing company officials' earlier testimony. The site says that "in time, we intend to share our innovations and solutions to help others."

In its suit, UnitedHealth's(UNH) Optum health-services unit has argued that the venture is a potential rival, and officials from the venture have said they aren't competing with Optum.

The website reiterates that Haven isn't meant to generate profits and will "reinvest any surplus back into our work."

The company says it will focus on priorities including improved access to primary care, simplifying insurance coverage and making prescription drugs more affordable -- all issues that were previously highlighted in court testimony. In a Q&A on the site, in answer to a question about whether Haven will look to replace patients' existing doctors and insurance companies, the company says it is "interested in working with clinicians and insurance companies to improve the overall health care system."

Write to Anna Wilde Mathews at anna.mathews@wsj.com

Corrections & Amplifications An earlier version of this article misspelled JPMorgan(JPM) as JPMorgen in the headline. (March 6, 2019)


(END) Dow Jones Newswires
03-07-190247ET
Copyright (c) 2019 Dow Jones & Company, Inc.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.